Feeds:
Posts
Comments

Posts Tagged ‘Dr. Buddhadeb Dawn’

Sen. Mary Pilcher-Cook, with health committee presenters: Dr. David Prentice, stem cell patient Richard Walters, Dr. Dana Winegarner, & Director Dr. Buddhadeb Dawn

Sen. Mary Pilcher-Cook, with health committee presenters: Dr. David Prentice, stem cell patient Richard Walters, Dr. Dana Winegarner, & Director Dr. Buddhadeb Dawn

What was once only a dream has become a reality– the Midwest Stem Cell Therapy Center at the University of Kansas Medical Center will host its inaugural in-depth educational conference about adult stem cell treatments Saturday, Nov. 23 in Kansas City. See details here.

The purpose of this conference (which provides continuing education credits) is to update health professionals and trainees about advances in therapy with adult stem cells, as well as explaining adult stem cell biology and its potential for tissue and organ regeneration.

Adult stem cell treatments in the form of bone marrow transplants have been used for many years to successfully treat leukemia and related bone/blood cancers. The scientific community is now focusing on additional therapeutic options including organ repair. The Midwest Stem Cell Therapy Center was created this year by the Kansas Legislature, (read here) under the leadership of Gov. Sam Brownback and Sen. Mary Pilcher-Cook, in order to:

  • facilitate the “translation” of basic stem cell research findings into actual clinical applications;
  • multiply clinical grade stem cells obtained from adult tissues, cord blood, and other sources, excluding embryonic and fetal;
  • increase the number of patients receiving stem cell treatments;
  • educate medical professionals and the public;
  • create and maintain a global database of available stem cell trials and therapies.

The Center’s director is Buddhadeb Dawn, M.D., current director of the KU Med Center’s Cardiovascular Division, who has been engaged in promising adult stem cell therapy for cardiac repair. International stem cell expert, Dr. David A Prentice, has been appointed to the Center’s 15-member advisory board.

Let your favorite medical personnel know about this exciting conference!

Read Full Post »

Sen. mary Pilcher-Cook

Sen.  Pilcher-Cook

An exciting proposal establishing an adult stem cell center at the University of Kansas Medical Center (KUMC), was presented to a joint meeting of the Kansas Senate and House Health committees on Thursday and Friday.

Lawmakers heard from medical experts using adult stem cell (ASC) treatments, as well as patients and other experts in the field about the urgent need to establish a new center at KUMC that would conduct clinical research trials and co-ordinate education about this rapidly growing medical specialty.

Dr. David Prentice, Adjunct Professor of Molecular Genetics and an international expert on the stem cell topic, has testified several times to Kansas lawmakers on this developing field. He urged the creation of a hub for ASC treatments, information and medical networking. Prentice quoted recent science and medical journals that:

  • 1 in 200 Americans will undergo an ASC transplant in their lifetime;
  • over 60,000 ASC transplants occur globally each year;
  • there are over 2,600 ongoing, or completed, FDA-approved ASC trials.

Dr. Dana Winegarner, a Kansas City neurologist, although not on staff at KUMC, testified that no professional turf battles stand in the way. The problem is that busy practitioners cannot keep up with the rapidity of the stem cell developments; he said he has an app on his smart phone that notifies of breaking relevant medical data and that it registers over 60 hits a day. “During the time I leave for work and return at night, medicine has changed!”

Dr. Buddhadeb Dawn, Director of KUMC’s Cardiovascular Diseases Division and Research Institute, demonstrated how applications of stem cells regenerate damaged hearts and reviewed outcomes of national studies. Dawn said the list of diseases that can be cured with stem cells is ever-increasing  and thus there is a crying need for a center that can process and manufacture clinical grade stem cells as well as initiate clinical trials.

Patient Richard Waters, a participant in an adult stem cell program trial at KUMC testified that the stem cell heart treatment he received last year was not available in the United States when he had his earlier heart attacks. Testimony from Waters and videos of two other patients who’d undergone successful, remarkable medical treatment from non-embryonic stem cells fascinated the attendees in the packed room at the state Capitol.

Dr. Omar Aljitawi, part of KUMC’s Blood and Marrow Transplant Program, said that KUMC is involved in 2 major umbilical cord blood transplant trials, a treatment first done successfully in 1988. Kansas is home to the development of the  “Wharton’s Jelly” part of the umbilical cord, which offers much promise as a base material for multiplying cells for patient application. Aljitawi bemoaned the fact that so many sources of ASC were being discarded, and need to be developed and made available for a waiting populace.

Senate Health committee chair, Mary Pilcher-Cook (R-Shawnee) said a bill is being drafted to create a cutting edge ASC center at the KUMC campus in Kansas City, for which no model exists nationally–or globally.

Read Full Post »

Follow

Get every new post delivered to your Inbox.

Join 41 other followers